Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001193125-15-374504
Filing Date
2015-11-12
Accepted
2015-11-12 06:17:18
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B1 d42123d424b1.htm 424B1 1641375
2 GRAPHIC g42123g10m91.jpg GRAPHIC 38100
3 GRAPHIC g42123g31u25.jpg GRAPHIC 96462
4 GRAPHIC g42123g45d07.jpg GRAPHIC 52270
5 GRAPHIC g42123g53n07.jpg GRAPHIC 67876
6 GRAPHIC g42123g59c90.jpg GRAPHIC 39284
7 GRAPHIC g42123g59h83.jpg GRAPHIC 35971
8 GRAPHIC g42123g60e35.jpg GRAPHIC 33327
9 GRAPHIC g42123g64l23.jpg GRAPHIC 50148
10 GRAPHIC g42123g65o09.jpg GRAPHIC 80868
11 GRAPHIC g42123g76s95.jpg GRAPHIC 76193
12 GRAPHIC g42123g78w05.jpg GRAPHIC 58988
13 GRAPHIC g42123g82f00.jpg GRAPHIC 48697
14 GRAPHIC g42123g95a09.jpg GRAPHIC 50239
  Complete submission text file 0001193125-15-374504.txt   2647709
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-207379 | Film No.: 151221212
SIC: 2834 Pharmaceutical Preparations